Interestingly, several studies have reported that a combination of biomarkers, including IGKC and IGHA1, has good prognostic value in clear cell renal cell carcinoma and autoimmune diseases (24, 25). This evidence concerns the gene IGHA1 and clear cell renal carcinoma.